Occupational exposures, biomarkers and neurodegenerative diseases

Authors

  • Giancarlo Logroscino – articles in this journal Corresponding author Email Department of Clinical Research in Neurology, Center for Neurodegenerative Diseases and the Aging Brain, “Pia Fondazione Cardinale G. Panico“, Tricase (LE); Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”, Bari, Italy.
  • Chiara Zecca – articles in this journal Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari “Aldo Moro”, Bari, Italy.
Published
24 February 2025
Section
ATTI 81° CONGRESSO NAZIONALE SIML
Pages
162-166

Abstract

Brain aging is marked by progressive changes and characterized at cellular, and organ dysfunction occurring in several areas of the brain. The main processes have all in common the deposition of proteins that the brain cannot metabolize anymore. While the aging processes is generalized and present in all individuals is characterized by great variability among individuals with a minority of subjects that are very healthyl even in very old age. Epidemiological and laboratory studies suggest that environmental and occupation exposures years or decades before a diagnosis can trigger the processes that ultimately result in a neurodegenerative disease. The major areas of research in occupational epidemiology will be revised with the role of heavy metals, organic solvents, and pesticides as the main focus of this report.
The public health especially in the field of occupational epidemiology of NDG diseases needs an integrated approach. This has been recently named convergence science, a transdisciplinary approach for a research which frames in the same convergence view several fields from epidemiology to physics, informatics, ecology to solve complex questions, including the role of occupation, in biomedicine.

References

  1. 1) Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013; 501(7465): 45-51. 2) Neurological diseases remain neglected and ignored. Lancet (London, England) 2012; 379(9813): 287. DOI: https://doi.org/10.1038/nature12481
  2. 3) Pearce N, Kromhout H. Neurodegenerative disease: the next occupational disease epidemic? Occupational and environmental medicine 2014; 71(9): 594-5. DOI: https://doi.org/10.1136/oemed-2013-101943
  3. 4) Sevigny J, Chiao P, Bussiere T, et al. The antibody aducanumab reduces Abeta plaques in Alzheimer's disease. Nature 2016; 537(7618): 50-6. DOI: https://doi.org/10.1038/nature19323
  4. 5) Baldi I, Lebailly P, Mohammed-Brahim B, et al. Neurodegenerative diseases and exposure to pesticides in the elderly. American journal of epidemiology 2003; 157(5): 409-14. DOI: https://doi.org/10.1093/aje/kwf216
  5. 6) Parron T, Requena M, Hernandez AF, et al. Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicology and applied pharmacology 2011; 256(3): 379-85. DOI: https://doi.org/10.1016/j.taap.2011.05.006
  6. 7) Weisskopf MG, Morozova N, O'Reilly EJ, et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis. Journal of neurology, neurosurgery, and psychiatry 2009; 80(5): 558-61. DOI: https://doi.org/10.1136/jnnp.2008.156976
  7. 8) Kamel F, Umbach DM, Bedlack RS, et al. Pesticide exposure and amyotrophic lateral sclerosis. Neurotoxicology 2012; 33(3): 457-62. 9) Malek AM, Barchowsky A, Bowser R, et al. Environmental and occupational risk factors for amyotrophic lateral sclerosis: a casecontrol study. Neuro-degenerative diseases 2014; 14(1): 31-8. 10) Gunnarsson LG, Lindberg G, Soderfeldt B, et al. Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta neurologica Scandinavica 1991; 83(6): 394-8. DOI: https://doi.org/10.1111/j.1600-0404.1991.tb03970.x
  8. 11) Granieri E, Carreras M, Tola R, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology 1988; 38(10): 1604-8. DOI: https://doi.org/10.1212/WNL.38.10.1604
  9. 12) Gash DM, Rutland K, Hudson NL, et al. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Annals of neurology 2008; 63(2): 184-92. DOI: https://doi.org/10.1002/ana.21288
  10. 13) Goldman SM, Quinlan PJ, Ross GW, et al. Solvent exposures and Parkinson disease risk in twins. Annals of neurology 2012; 71(6): 776-84. 14) Kukull WA, Larson EB, Bowen JD, et al. Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. American journal of epidemiology 1995; 141(11): 1059-71; discussion 72-9. 15) Graves AB, van Duijn CM, Chandra V, et al. Occupational exposures to solvents and lead as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. International journal of epidemiology 1991; 20 Suppl 2: S58-61.
  11. 16) Gunnarsson LG, Bodin L, Soderfeldt B, et al. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. British journal of industrial medicine 1992; 49(11): 791-8. DOI: https://doi.org/10.1136/oem.49.11.791
  12. 17) Chancellor AM, Slattery JM, Fraser H, et al. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. Journal of neurology, neurosurgery, and psychiatry 1993; 56(11): 1200-6. DOI: https://doi.org/10.1136/jnnp.56.11.1200
  13. 18) Morahan JM, Pamphlett R. Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control study. Neuroepidemiology 2006; 27(3): 130-5. DOI: https://doi.org/10.1159/000095552
  14. 19) Fang F, Quinlan P, Ye W, et al. Workplace exposures and the risk of amyotrophic lateral sclerosis. Environmental health perspectives 2009; 117(9): 1387-92. DOI: https://doi.org/10.1289/ehp.0900580
  15. 20) Park RM, Schulte PA, Bowman JD, et al. Potential occupational risks for neurodegenerative diseases. American journal of industrial medicine 2005; 48(1): 63-77. DOI: https://doi.org/10.1002/ajim.20178
  16. 21) Finkelstein MM, Jerrett M. A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. Environmental research 2007; 104(3): 420-32. DOI: https://doi.org/10.1016/j.envres.2007.03.002
  17. 22) Calderon-Garciduenas L, Franco-Lira M, Mora-Tiscareno A, et al. Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses—it is time to face the evidence. BioMed research international 2013; 2013: 161687. 23) Callaghan B, Feldman D, Gruis K, et al. The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Neuro-degenerative diseases 2011; 8(1-2): 1-8. DOI: https://doi.org/10.1159/000315405
  18. 24) Crapper DR, Krishnan SS, Dalton AJ. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science (New York, NY) 1973; 180(4085): 511-3. 25) Perl DP, Moalem S. Aluminum and Alzheimer's disease, a personal perspective after 25 years. Journal of Alzheimer's disease : JAD 2006; 9(3 Suppl): 291-300. DOI: https://doi.org/10.1126/science.180.4085.511
  19. 26) Schulte PA, Burnett CA, Boeniger MF, et al. Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991. American journal of public health 1996; 86(9): 1281-8. DOI: https://doi.org/10.2105/AJPH.86.9.1281
  20. 27) Savitz DA, Loomis DP, Tse CK. Electrical occupations and neurodegenerative disease: analysis of U.S. mortality data. Archives of environmental health 1998; 53(1): 71-4. DOI: https://doi.org/10.1080/00039899809605691
  21. 28) Sorahan T, Mohammed N. Neurodegenerative disease and magnetic field exposure in UK electricity supply workers. Occupational medicine (Oxford, England) 2014; 64(6): 454-60. DOI: https://doi.org/10.1093/occmed/kqu105
  22. 29) Ritchie GD, Still KR, Alexander WK, et al. A review of the neurotoxicity risk of selected hydrocarbon fuels. Journal of toxicology and environmental health Part B, Critical reviews 2001; 4(3): 223-312. DOI: https://doi.org/10.1080/109374001301419728
  23. 30) Liu Z, Zhou T, Ziegler AC, et al. Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications. Oxidative medicine and cellular longevity 2017; 2017: 2525967. DOI: https://doi.org/10.1155/2017/2525967
  24. 31) Dzau VJ. BCA. Reimagining population health as convergence science. The Lancet 2018; 392 (10145): 367-8. DOI: https://doi.org/10.1016/S0140-6736(18)31372-2

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.